Pipeline Conference

Save the Dates: March 12-13, 2020, in Santa Clara, California

Every two years, the Epilepsy Foundation holds its Pipeline Conference to bring together decision-makers with a stake in the field of epilepsy treatment, therapeutic innovation, and product development. This exciting meeting provides a forum for surveying new therapies in development, exploring future advancements, and encouraging collaborations and partnerships.

Registration Opens November 2019

The 2020 Pipeline Conference will take place March 12-13, 2020, at the Santa Clara Marriott in Santa Clara, California. This conference will also feature a Community Day on Saturday, March 14, 2020, where people living with epilepsy and their family, friends, and supporters gather for a day of learning, support, and networking. The event will also include the 2020 Epilepsy Foundation Shark Tank Competition.

Speakers and attendees will include:

  • Emerging biotech and medical technology companies
  • Major pharmaceutical and device companies
  • Researchers and innovators at the cutting edge of epilepsy and central nervous system treatment advances
  • Investors and venture capitalists

For more information on the Pipeline Conference, Community Day and other events during the meeting (including an Investment and Partnering session), please share your contact information and we will follow up with you.

More details (agenda, registration, hotel accommodation, etc.) will be forthcoming. Please watch this space for more information.

Conference Agenda

Times are pacific standard time (PST).

Day 1 – Thursday, March 12, 2020

Welcome and Overview – 8:00-8:15 A.M.

Session I: We know where we've been. Do we know where we are going? – 8:15-9:05 a.m.

  • Past Successes
  • Future Challenges

Session II: Technology for Behavior Change – 9:05-9:55 A.M. 

  • Experiences from Outside the Epilepsy Space
  • Digital Strategies: What are the shots on the goal? 

Networking Break – 9:55-10:15 A.M.

Session III: RED (Risk for Epilepsy Development) Syndrome – 10:20-11:25 A.M.

  • Who is at risk?
  • How to Identify People at Risk
  • "So I've identified a RED group. Now what?"

Session IV: Diagnosis & Detection Devices – 11:30-12:40 P.M.

  • Can SUDEP be avoided with devices?

Networking Lunch – 12:45-1:45 P.M.

Session V: Therapeutic Devices and Drug/Device Combinations – 1:45-2:10 P.M. 

Session VI: Title Coming Soon – 2:10-2:50 P.M.

Session VII: Investor Panel – 2:50-3:20 P.M.

Networking Break – 3:20-3:40 P.M.

Update from 2019 Shark Tank Winners – 3:40-5:30 P.M.

Accelerator Award Reception & Presentation – 6:00-8:00 P.M.

Day 2 – Friday, March 13, 2020

Status Report on NINDS Translational Epilepsy Research – 8:00-8:20 A.M.

Session VIII: Genetics – 8:20-9:30 A.M.

  • When is the damage done?
  • Mechanism of Intervention in Single Gene Disease

Session IX: Data-Driven Solutions – 9:30-10:50 A.M.

Networking Break – 10:50-11:10 A.M.

Session X: Efficient Trials and Ultra-Rare Diseases – 11:10-11:55 A.M.

  • Seizure Counting
  • Novel Trial Designs Compared to Standard Designs
  • Definitively Evaluating Effectiveness in Very Small Populations

Networking Lunch – 12:25-1:15 P.M.

Session XI: What We Still Need in Drugs for Focal Epilepsy – 1:20-2:15 P.M.

Session XII: What will be the next big advances for epilepsy?

Closing Remarks – 2:40-3:00 P.M.

Final Networking Reception – 3:00-4:30 P.M.

Watch Footage from the 2018 Pipeline Conference

Authored By: 
Research Team
Authored Date: